|

Overview
High-throughput nucleic-acid based technologies are revolutionizing modern biology. While PCR is the backbone of molecular biological research, it has not achieved the same throughput as more recent technologies such as microarrays and parallel whole genome sequencing. Whatever technology is selected, success depends on a balanced combination of good experimental design, sample preparation, probe design, amplification, detection, and analysis as well as selection of equipment and reagents. New technical developments that improve the performance of nucleic acid amplification and detection, as well as practical examples of how these techniques are used, is the emphasis of Cambridge Healthtech Institute’s 13th Annual Nucleic Acid-Based Technologies meeting. Learn from savvy, seasoned researchers as they share their experiences with the latest technologies and their cutting edge results.
Kick-off Keynote
Dr. Frederick Blattner, University of Wisconsin
Distinguished Faculty
Dr. Y. Paul Bao, Nanosphere Inc.
Mr. Fredrik Dahl, Uppsala University
Dr. Garth Ehrlich, Allegheny Singer Research Institute
Dr. Olga Genilloud, Merck Sharp and Dohme España S.A
Dr. Robert Getts, Genisphere Inc.
Dr. Scott A. Jackson, Food and Drug Administration
Mr. Robert Jenison, Thermo Electron
Dr. Dan Mercola, Sidney Kimmel Cancer Center
Dr. Ellen Murphy, Wyeth Vaccines Research
Dr. Charles Rogler, Albert Einstein College of Medicine
Dr. Tian-Li Wang, Johns Hopkins Medical Institutions
SCIENTIFIC ADVISORS
Dr. Michael Egholm, 454 Life Sciences
Dr. Scott Jackson, Food and Drug Administration
|
NEW! -
Tech Talk: Interactive Facilitated Networking Discussions
|
• Biomarker Identification
• Cancer Prognosis and Diagnosis
• Emerging Infectious Diseases
• Food Safety
• Microbial Forensics
• MicroRNAs |
• Multiplexing
• Rapid Pathogen Detection
• Real-time PCR
• RNA Viruses
• Validating Microarray Results
• Whole Genome Amplification |
|
|